Alternatives to mediQ

A health technology company offering a white-label software suite for building and operating telehealth businesses.

Develops a brain-computer interface for treating epilepsy.

Develops intravascular lithotripsy technology for treating calcified cardiovascular lesions.

Medical device company developing and commercializing clot removal devices for venous diseases.

Saluda Medical is a commercial-stage medical device company that develops treatments for chronic neurological conditions.

AI-powered EEG device for rapid seizure detection in critical care.

Develops an AI-driven surgical navigation platform using 3D ultrasound for enhanced cancer treatment.

Develops a minimally invasive implantable device for treating type 2 diabetes and obesity.

Develops and commercializes minimally invasive robotic platforms for the neuroscience field.

Develops a point-of-care diagnostic platform for rapid and accurate disease detection.

Developing minimally invasive water vapor ablation therapy to treat prostate, kidney, and bladder cancer.

CairnSurgical is developing the Breast Cancer Locator™ System to improve breast-conserving surgery by enhancing tumor localization and tissue inspection.

Medical technology company developing anesthesia-free kidney stone treatment.

Develops innovative surgical technology to make bone surgery safer and more precise by protecting soft tissues.

Pioneering bio-engineered skin grafts for severe burns and chronic wounds.

Femasys is a biomedical company developing minimally invasive, in-office technologies for women's reproductive health, including fertility and permanent birth control solutions.

TytoCare provides a Home Smart Clinic solution enabling accessible, high-quality primary care from home through remote physical exams.

A consortium focused on incubating and developing technology in the medtech and pharma sectors in Israel.

Develops advanced wound care solutions utilizing proprietary bio-active materials.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).